BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 23, 2019
View Archived Issues
Amgen presents first-in-human data for AMG-595 in patients with recurrent glioblastoma
Read More
Saniona selects IK channel inhibitor SAN-903 as new preclinical candidate
Read More
Cell Pouch is well tolerated and shows signs of efficacy in type 1 diabetes patient
Read More
ACCORDANCE study of AP-CD/LD does not achieve statistical superiority on the primary endpoint
Read More
Achillion presents promising data from phase I MAD study of ACH-5228
Read More
First patient treated in phase I/II study of sapacitabine and venetoclax in AML or MDS
Read More
Patrys presents promising preclinical data for PAT-DX1 in models of highly aggressive GBM
Read More
Spectrum expands ZENITH20 phase II study of poziotinib
Read More
Sun BioPharma offers update on front-line pancreatic cancer study of SBP-101
Read More
WMJ-J-2 as a promising new preclinical candidate for the treatment of CRC
Read More
Discovery and preclinical identification of novel NOX1-selective inhibitor, 2APT-PD06
Read More
First-generation PI3KC2alpha inhibitors as promising antithrombotic agents
Read More
Metabolic disorder and neuroinflammation alleviated by novel CB1 receptor antagonist in AD models
Read More
Daewoong Pharmaceutical describes new BTK and/or JAK3 inhibitors
Read More
Shanghai Institute of Cell Therapy, Shanghai Cell Therapy Group patent EGFR-specific CAR-T cells
Read More
Innovent Biologics presents antibodies targeting LAG-3, PD-L1
Read More
Hepatitis B virus HBsAg and DNA inhibitors discovered at Roche
Read More
RIKEN and collaborators describe tankyrase and/or tubulin polymerization inhibitors
Read More
BK-40143: a novel small-molecule inhibitor of discoidin domain receptors
Read More
Parkinson's other balance problem
Read More
GLP-1/GIP dual antagonist mitigates pilocarpine-induced neurotoxicity in rats
Read More
New assays mean new insights into HIV reservoir
Read More
Arcutis reports promising topline phase IIb data on ARQ-151 for plaque psoriasis
Read More
Salarius enrolls first patient in phase I study of seclidemstat in advanced solid tumors
Read More
Dolutegravir recommended by WHO for first-line and second-line treatment for HIV
Read More
Acadia reports phase III topline results on pimavanserin as adjunctive treatment for schizophrenia
Read More
Japanese phase III study of Lonasen in adolescents with schizophrenia meets primary endpoint
Read More
VenatoRx announces collaboration to develop VNRX-5133 to treat drug-resistant infections
Read More